The pharmacological inhibition of arachidonate 5-lipoxygenase (5-LOX) and microsomal prostaglandin E synthase-1 (mPGES-1) led to reversal of the NKT population, enhanced CD8+ T cells, and tumor suppression [207]. The gene discussed is CD8A; the disease is neoplasm.